Sort
8,912 grants matching “sars cov 2”
Strengthening the Dementia Care Workforce: Analyzing Economic Policies' influence on Workers and their Patients Living with Dementia
$634,545Norma B Coe · University Of Pennsylvania · R01 · FY2025 · AG
Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection
$634,369Jianwen Que · Columbia University Health Sciences · R01 · FY2021 · HL
Inhalation Therapy Platform for Coronavirus Infection Treatment
$634,365Patrick S. Stayton · University Of Washington · R01 · FY2021 · AI
Single-cell atlas of lung tissue-resident memory T cells reactive to upper and lower respiratory tract pathogens
$634,314Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2023 · AI
Roles for virus-derived circular RNAs during RNA virus infections
$634,198Peter Sarnow · Stanford University · R56 · FY2025 · AI
Immune dysregulation mechanisms of persistent post-COVID19 olfactory dysfunction
$634,157Lora Bankova · Brigham And Women'S Hospital · R01 · FY2025 · DC
Determining the Incidence, Risk Factors and Biological Drivers of Irritable Bowel Syndrome (IBS) as Part of the Constellation of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Outcomes
$634,144Kristen M Pogreba-Brown · University Of Arizona · R01 · FY2024 · DK
Unraveling Human T Follicular Helper Cell Development
$634,142Philip A Mudd · Washington University · R01 · FY2025 · AI
The Immunobiology of Vaccine-induced Immune Thrombotic Thrombocytopenia
$633,990Mortimer Poncz · Versiti Blood Health, Inc. · P01 · FY2025 · HL
Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention
$633,875Steve W Cole · University Of California Los Angeles · R01 · FY2024 · AG
Increasing COVID-19 Vaccine Uptake among Latinos through a Targeted Clinical and Community-behavioral Intervention
$633,539Noe Cuauhtemoc Crespo · San Diego State University · R01 · FY2022 · MD
Small GTP Binding Proteins in Gastrointestinal Mucosa
$633,524James R Goldenring · Vanderbilt University Medical Center · R01 · FY2021 · DK
MEDSCAN: Mobile Enabled Diagnostics for Schistosomiasis Control Analytics
$633,392Thomas F Scherr · Vanderbilt University · R01 · FY2023 · AI
Longitudinal analysis to determine persistence of T cell responses induced by SARS-CoV-2 vaccination, natural infection with SARS-CoV-2, and human common cold coronaviruses
$633,253Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2025 · AI
Modeling Adolescent Health Care Decision-Making for Vaccines: A Community- Based Participatory Approach
$633,148Kar-Hai Chu · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HD
Pathogenic Mechanism and Therapeutic Approaches for Exercise Intolerance in Post-Acute Sequelae of COVID-19
$633,045Lianghui Zhang · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
Viral Oral Infections in Immunosuppression and Cancer Section
$633,042William Seaman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Clinical Core
$632,901Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2020 · AI
Epidemiology of SARS-CoV-2 in Low-income Countries.
$632,901Carl F Nathan · Weill Medical Coll Of Cornell Univ · U19 · FY2020 · AI
A multipronged investigation of SARS-CoV-2 genome packaging
$631,912Andrea Soranno · Washington University · R01 · FY2022 · AI
Training Program in Infectious Diseases in the Immunocompromised Host
$631,728Michael J Boeckh · Fred Hutchinson Cancer Center · T32 · FY2025 · AI
Viral Noncoding RNAs and Cell Transformation
$631,557Joan A. Steitz · Yale University · R01 · FY2024 · CA
Pathogenic mechanisms of Neuro-PASC in older adults
$631,557Kristen Knutson · Northwestern University At Chicago · R01 · FY2022 · AG
Viral Noncoding RNAs and Cell Transformation
$631,557Joan A. Steitz · Yale University · R01 · FY2025 · CA
Culturally-targeted communication to promote SARS-CoV-2 antibody testing in saliva: Enabling evaluation of inflammatory pathways in COVID-19 racial disparities
$630,937Todd William Lucas · Michigan State University · U01 · FY2022 · CA